Hypercoagulability in Children with Thalassemia Major

Clinical and Applied Thrombosis/Hemostasis

Volumn 3, Issue 2, 1997, Pages 129-132

  Kemahli, Sabri ^a   Gürman, Ceyda ^a   Egin, Yonca ^a   Yildirmak, Yildiz ^a   Sipahi, Tansu ^a   Uysal, Zümrüt ^a   Akar, Nejat ^a   Cin, Şükrü ^a   Arcasoy, Ayten ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Antiphospholipid antibodies; Antithrombin; Hypercoagulability; Protein C; Protein S; Thalassemia

Indexed keywords

EID: 84996154917     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602969700300211     Document Type: Article

References (11)

1. Borenstein-Ben Yashar V., Barenholz YT, Hy-Am E., Rachmilewitz EA, Eldor A. Phosphatidylserine in the outer leaflet of red blood cells from β-thalassaemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol 1993; 44: 63-65.
2. Eldor A., Lellouche F., Goldfarb A., Rachmilewitz EA, Mactouf J. In vivo platelet activation in β-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. Blood 1991; 77: 1749-53.
3. Sinniah HD, Vignaendra V., Kamaruddin A. Neurological complication of β-thalassemia major. Arch Dis Child 1977; 52: 977-9.
4. Kemahli S., Canatan D., Erden I., Akar N., Cin ^., Arcasoy A. Postsplenectomy thrombosis in haemolytic anaemias. Throm Haemost 1993; 69: 1358.
5. Eldor A., Maclouf J., Durst R., Hy-Am E., et al. A life-long hypercoagulable state in beta-thalassemia major is associated with in-vivo platelet activation, protein C and protein S deficiency and enhanced erythrocyte procoagulant activity and aggregation. Thromb Haemost 1993; 69: 968.
6. Hurlet-Jensen A., Morris V., Guarini L., Boffa MC, Piomelli S. Protein C and protein S deficiencies in chronically transfused patients with hemoglobinopathy. Thomb Haemost 1991; 65: 1206.
7. Musumeci S., Leonardi S., Di Rio R., Fischer A., Di Costa G. Protein C and antithrombin III in polytransfused thalassemic patients. Acta Haematol 1987; 77: 30-33.
8. Shirahata A., Funahara Y., Opartkiattikul N., Fucharoen S., Laosombat V., Yamada K. Protein C and protein S deficiency in thalassemic patients. Southeast Asian J Trop Med Public Health 1992; 23(suppl 2):65-73.
9. O'Driscoll A., Mackie I., Young L., Porter J., Machin S. Heparin cofactor II levels are reduced in untransfused patients with thalassaemia intermedia but normal in transfused thalassaemia major. Thromb Haemost 1993; 69: 899.
10. Porter JB, Young L., Mackie IJ, Marshall L. Machin SJ Sickle cell disorders and.chronic intravascular haemolysis are associated with low plasma heparin cofactor II. Br J Haematol 1993; 83: 459-65.
11. Kucuk O., Gilman-Sachs A., Beaman K., Lis LJ, Westerman MP Antiphospholipid antibodies in sickle cell disease. Am J Hematol 1993, 42: 380-3.